Almut Winterstein, Ph.D.

Almut Winterstein

Chair & Professor

Graduate Courses Taught
PHA 6265 / PHA 6266 – Introduction to Pharmaceutical Outcomes and Policy
PHA 6717 – Measurement in Pharmaceutical Outcomes and Policy Research

Why would you recommend that others should consider joining one of the programs of graduate study in POP?

“Based on my training and interest I have one of my feet in pharmacoepidemiology and the other in patient safety and program evaluation. Having methodological and clinical training, I consider these areas to be very complementary. It is with no exaggeration when I say that our Department has one of a handful of graduate programs in the US that offers Ph.D. level training in pharmacoepidemiology and that can expose students to ongoing research that reflects the core of this area. Our faculty is engaged in key positions related to drug safety and comparative effectiveness research and is able to position future graduates within an excellent network of peers. We have a wealth of data sources for population-based retrospective analyses and an excellent academic health center across the street with access to state-of-the art electronic health records. It is the latter that offers one of the most important opportunities for patient safety research as many quality improvement studies have generated there. Currently UF & Shands will engage with our department in an effort with FMQAI and CMS to develop a new set of inpatient quality measures for Medicare beneficiaries.

To summarize, our department offers more opportunities to students for immersion in research than can be fully taken advantage of. While we have the luxury to offer a comprehensive curriculum with a good set of advanced methodological courses, I value the research experience as equally important and as equally superb. To get a better impression please review our faculty’s CVs.”